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Attachment to laminin-111 facilitates transforming growth factor
beta-induced expression of matrix metalloproteinase-3 in
synovial fibroblasts
Abstract
BACKGROUND: In the synovial membrane of patients with rheumatoid arthritis (RA), a strong
expression of laminins and matrix degrading proteases was reported. Aim: To investigate the regulation
of matrix metalloproteinases (MMPs) in synovial fibroblasts (SFs) of patients with osteoarthritis (OA)
and RA by attachment to laminin-1 (LM-111) and in the presence or absence of costimulatory signals
provided by transforming growth factor beta (TGFbeta). METHODS: SFs were seeded in
laminin-coated flasks and activated by addition of TGFbeta. The expression of genes was investigated
by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), immunocytochemistry and
ELISA, and intracellular signalling pathways by immunoblotting, and by poisoning p38MAPK by
SB203580, MEK-ERK by PD98059 and SMAD2 by A-83-01. RESULTS: Attachment of SF to LM-111
did not activate the expression of MMPs, but addition of TGFbeta induced a fivefold higher expression
of MMP-3. Incubation of SF on LM-111 in the presence of TGFbeta induced a significant 12-fold
higher expression of MMP-3 mRNA, and secretion of MMP-3 was elevated 20-fold above controls.
Functional blocking of LM-111-integrin interaction reduced the laminin-activated MMP-3 expression
significantly. Stimulation of SF by LM-111 and TGFbeta activated the p38MAPK, ERK and SMAD2
pathways, and inhibition of these pathways by using SB203580, PD98059 or A-83-01 confirmed the
involvement of these pathways in the regulation of MMP-3. CONCLUSION: Attachment of SF to
LM-111 by itself has only minor effects on the expression of MMP-1 or MMP-3, but it facilitates the
TGFbeta-induced expression of MMP-3 significantly. This mode of MMP-3 induction may therefore
contribute to inflammatory joint destruction in RA independent of the proinflammatory cytokines
interleukin (IL)1beta or tumour necrosis factor (TNF)alpha.
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ABSTRACT 
 
Objectives: 
In the synovial membrane of rheumatoid arthritis (RA) patients, a strong expression of 
laminins and matrix degrading proteases was reported. We therefore investigated the 
regulation of matrix metalloproteinases (MMP) in synovial fibroblasts (SF) of osteoarthritis 
(OA) and RA patients by attachment to laminin-1 (LM-111) and in the presence or absence of 
co-stimulatory signals provided by transforming growth factor- (TGF-ß). 
Methods:  
SF were seeded in laminin-coated flasks and activated by addition of TGF-ß. The expression 
of genes was investigated by qRT-PCR, immunocytochemistry, and ELISA, and intracellular 
signaling pathways by immunoblotting, and by poisoning p38MAPK by SB203580, MEK-
ERK by PD98059, and SMAD2 by A-83-01. 
Results: 
Attachment of SF to LM-111 did not activate the expression of MMPs, but addition of TGF-ß 
induced a five-fold higher expression of MMP-3. Incubation of SF on LM-111 in the presence 
of TGF-ß induced a significant twelve fold higher expression of MMP-3 mRNA and secretion 
of MMP-3 was elevated twenty fold above controls. Functional blocking of LM-111 - integrin 
interaction reduced the laminin-activated MMP-3 expression significantly. Stimulation of SF 
by LM-111 and TGF-ß activated the p38MAPK, ERK and SMAD2 pathways and inhibition 
of these pathways by utilizing SB203580, PD98059, or A-83-01, confirmed the involvement 
of these pathways in the regulation of MMP-3. 
Conclusion: 
Attachment of SF to LM-111 by itself has only minor effects on the expression of MMP-1 or 
MMP-3 but it facilitates the TGF- induced expression of MMP-3 significantly. This mode 
of MMP-3 induction may therefore contribute to inflammatory joint destruction in RA 
independent of the pro-inflammatory cytokines IL-1ß or TNF-.  
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INTRODUCTION 
 
In the course of rheumatoid arthritis (RA), fibroblast-like cells of the synovial tissue become 
activated and express elevated levels of matrix degrading proteases and cytokines [1, 2]. 
Among the cytokines found to be elevated in RA synovial tissue or fluid, pro-inflammatory 
factors such as IL-1ß and TNF- contribute to synovial pain, swelling and cartilage 
degradation [3, 4]. Mitogenic factors such as TGF-ß1 or bFGF may promote synovial 
hyperplasia [5]. However, the synovial fibroblasts (SF) do not only respond to cytokines. 
Interactions of these cells with extracellular matrix proteins such as fibronectin, collagens and 
laminins may activate SF and thus contribute to both articular pathologies in RA, synovial 
inflammation and hyperplasia [6, 7]. It has been shown that fibroblast-like synoviocytes 
express elevated levels of integrins, which correlate with their enhanced binding to matrix 
proteins [8, 9]. Integrin engagement is known to induce proliferation of SF [10]. Binding of 
intact fibronectin to cells via integrins suppressed the induction of matrix metalloproteinases 
(MMPs), but fibronectin fragments induced elevated MMP expression [11]. Further, 
attachment to fibronectin suppressed p53-mediated apoptosis of fibroblasts [7, 12]. Thus 
interaction of extracellular matrix compounds with SF can modulate the joint pathology in RA 
or other disorders.  
 
Laminins (LM) are heterotrimeric, extracelllular matrix proteins. Laminins are composed of 
an -, - and -chain. In the human genome five -, three - and three -chains encoding 
genes have been identified and characterized. To date sixteen laminin isoforms are known, 
designated LM-111 to LM-523 [13]. Elevated expression of different isoforms of laminins 
was reported in RA specimen when compared to osteoarthritis (OA) samples [8]. Binding to 
laminin fragments or laminin derived peptides induced elevated expression of different MMPs 
in macrophages [14, 15]. In mice, LM-111, previously termed LN-1, is typically expressed 
early in embryogenesis [16]. In the adult organism it shows a rather limited expression 
pattern, but LM-111 was found to be expressed in tumor cells, in normal adult brain, kidney, 
testis, placenta, adrenal gland, liver, and in cultured cells [16, 17], and it was up-regulated in 
the airway in a murine asthma model [18]. In humans, elevated LM-111 expression was 
described in endometriotic lesions and anti-LM-111 autoantibodies were found in infertile 
patients [19]. Enhanced expression of LM-111 was also reported in astrocytes of diseased 
areas in the frontal cortex of Alzheimer’s brain tissues [20], and reduced expression was 
observed in acinar basement membranes of Sjögren’s syndrome patients [21], indicating that 
laminin expression patterns change during pathologic processes. 
 
In the RA synovial tissue elevated levels of integrin receptors and laminins co-localize in the 
synovial lining layer with elevated expression of MMPs [8]. There, it was hypothesized that 
stimuli contributing to enhanced integrin or laminin expression might also induce MMPs in 
synovial cells. However, the metabolic changes in SF upon attachment to laminins have not 
been studied so far. We reasoned that attachment of RA-SF to laminin via integrin could also 
modulate the expression of MMPs and, therefore, set out to investigate whether attachment to 
laminins influences the expression of MMP-1 and MMP-3, two important proteases 
contributing to cartilage degradation in joints of RA patients. 
 
We report that TGF-ß activates SF to produce, upon attachment to LM-111, twenty-fold more 
MMP-3 when compared to mock-treated controls. Synovial fibroblasts bind to LM-111 
through integrin receptors and blocking of ß1-integrins reduced this effect of co-activation. 
The TGF-ß induced expression of MMP-3 is mediated through the ERK and SMAD2 
pathways and enhanced by phosphorylation of p38MAPK and extended or intensified 
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phosphorylation of ERK upon LM-111 binding. The SAPK/JNK-1 seems to regulate the 
expression of MMP-3 as well. 
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MATERIALS AND METHODS 
 
Cell culture 
Synovial fibroblasts were isolated from surgical samples of sixteen RA patients diagnosed 
according to the revised American College of Rheumatology (ACR) criteria for RA and 
twelve OA patients after written consent [22] (Table 1). The cells were expanded in vitro as 
described [23]. In brief, fibroblasts were isolated from synovial membranes by cutting the 
tissue, followed by enzymatic degradation, and expanded for 3 to 4 passages in 10% FCS-
DMEM medium. All studies were approved by the local ethics committee.  
 
Table 1 
Diagnosis # of 
patients 
gender mean age mean 
CRP 
mean 
BSR 
DMARD steriods NSAR 
RA 16 m 7 / w 9 61.8 0.77 29.1 13 / 16 10 / 16 4 / 16 
OA 12 m 5 / w 7 66.2 0.41 14.3 0 / 14 1 / 112 12 / 12 
 
Patients included in the study 
 
For induction experiments, cells were stimulated for 24 h with 10 ng/mL rhTGF-1, or were 
incubated on LM-111-coated or LM-511/521-coated flasks. Cells incubated in uncoated cell 
culture flasks w/o TGF-ß served as controls. 
 
To modulate the effects of laminin, SF were pre-incubated with 10 g/mL anti-CD29 
monoclonal antibodies (anti-1 integrin, clone 4B4, Beckman Coulter) for 60 min on ice to 
block integrin receptors. Then the cells were incubated for 24 h in the presence or absence of 
TGF-ß and LM-111 and changes in the expression of MMPs were enumerated by qRT-PCR. 
 
Cell signaling 
To investigate signal transduction pathways, cells were incubated on LM-111, in presence of 
10 ng/mL rhTGF-ß1, or on LM-111 plus TGF-ß. Untreated cells served as controls. To block 
the p38MAPK pathway 20 M SB203580 [24], to block the MEK-ERK pathway 20 M 
PD98059 [25], to block TGF-ß dependent SMAD-2 signaling ALK-5 blocker A-81-01 (100 
nM, TGF-ßR-I serin/threonine kinase blocker [26], all from Calbiochem) were used. After 
overnight incubation cells were harvested to measure changes in the expression of genes by 
quantitative RT-PCR. 
 
Transcript Analysis 
The RNA was extracted from cells using a spin column technique (RNeasy, Qiagen, Hilden, 
FRG) to generate cDNA. Gene-specific cDNA was enumerated by quantitative RT-PCR 
(qRT-PCR, LightCycler®, Roche) using commercially available primer pairs (SearchLC, 
Heidelberg, FRG). The qRT-PCR was performed as touch-down PCR in 35 PCR cycles 
(denaturing: 95°C 10 sec, annealing: 5 cycles 68°C 10 sec, then touch-down to 58°C 10 sec, 
extension: 72°C 16 sec). Quantification of GAPDH mRNA and a recombinant standard DNA 
(Roche) served as controls in each PCR [27]. To detect LM-111 mRNA, end-point RT-PCRs 
were performed (30 cycles; denaturing: 94oC, 60 sec, annealing: 56oC 60 sec, extension: 
72oC, 120 sec, respectively), and amplification products were separated and visualized on 
agarose gels. 
 
 
ELISA 
The secretion of MMPs was measured in SF supernatants by ELISA. The cells were seeded in 
flasks, activated for 24 h by addition of 10 ng/mL rhTGF-, by attachment to LM-111, or 
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with both stimuli. Controls were incubated in uncoated cell culture flasks w/o TGF-or LM-
111. Supernatants were harvested after 24 h of incubation, pre-cleared by centrifugation 
(20000xg, 4°C, 5 min) and MMPs were measured by ELISA (R&D Systems).  
 
Immunoblot Analysis 
Cells were stimulated by LM-111 and TGF-ß, harvested, lysed and subjected to SDS-PAGE 
and immunoblot analysis as described [28]. Aliquots of 100 g cellular protein were mixed 
with Laemmli sample buffer, denatured and then separated by electrophoresis in a 10% SDS-
PAGE. Proteins were transferred onto Nylon membranes, blocked and probed overnight at 
4°C with mAb specific for phospho-p38MAPK (Thr180/Tyr182), total-p38MAPK, phospho-
ERK1/2 (Thr202/Tyr204), phospho-JNK/SAPK (Thr183/Thr185), phospho-SMAD2 
(Ser465/467; all from Cell Signaling Technology, Beverly, MA). After rinsing of the 
membrane, binding of the primary antibodies was detected by peroxidase-labelled goat anti-
rabbit-IgG antiserum (Dianova). The binding of antisera was visualized by enhanced 
chemoluminescence (ECL, Amersham Biosciences, Freiburg, FRG) and recorded by a 
luminescence-sensitive CCD camera system (Diana, Raytest Inc. Straubenhardt, FRG).  
 
Statistics 
Experimental data were analyzed by a two-sided modified Student’s t-test and p-values of 
data sets equal of lower than 0.05, 0.01 or 0.001 were considered to be statistically significant 
and marked accordingly (*, **, ***). Each data point given represents the mean value ± 
standard deviation from individual experiments using SF from n different patients (4 ≤ n ≤ 
14). A detailed description of all specimen including, materials and methods is found in the 
complementary files published online. 
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RESULTS 
 
Regulation of MMP expression by TGF-ß and by attachment to laminin-111 
 
Elevated expression of laminin [8] and elevated concentrations of growth factors including 
TGF-ß are reported in RA synovial fluid [29]. Expression of LM-111 by SF in vitro was 
confirmed (see Fig. S1, complementary files). Attachment of SF to LM-111 coated flasks 
without additional stimulation induced only slight, but statistically significant increases of 
MMP-1 (2.3-fold ± 1.61, p≤0.015) or MMP-3 mRNA (1.49-fold ± 0.66, p≤0.037, Fig. 1A). 
This moderate induction was also observed with other batches of LM-111, and in the presence 
of anti-TGF-ß antiserum (not shown). In addition, incubation of SF on LM-511 was 
investigated as well, but an effect of LN-511 onto MMP expression was not observed (not 
shown). Activation of SF by 10 ng/mL TGF-ß1 resulted in a significant induction of MMP-3 
mRNA (5.3-fold ± 3.13, p≤0.018), but no effects on expression of MMP-1 mRNA (Fig. 1A). 
Incubation of SF in LM-111 coated flasks in presence of 10 ng/mL TGF-ß augment the 
expression MMP-1 mRNA to some extent (2.73-fold ± 1.0, p≤0.004) but a significantly 
stronger induction of MMP-3 encoding message (14.21-fold ± 7.27, p<0.004, Fig. 1A) was 
observed. This expression of MMP-3 was significantly higher when compared to the 
expression of MMP-1 (5.2-fold p≤ 0.018). A difference in the induction patterns of MMP-1 or 
MMP-3 between RA-SF and OA-SF was not observed. The induction of tissue inhibitors of 
metalloproteinases (TIMP’s) and other MMP’s was less pronounced (not shown). 
 
The release of MMP-1 and MMP-3 was confirmed by ELISA (Fig. 1B). SF produced 
spontaneously some MMP-1 (mean 49 pg/mL), but activation of the production of MMP-1 
was not induced significantly by either method (mean 70 to 123 ng/mL, Fig. 1B). SF 
spontaneously expressed less MMP-3 (mean 25 ng/mL), but substantially more upon 
activation with TGF-ß (7-fold, ± 0.92 induction, p≤ 0.012, mean 168 ± 16 ng/mL). The 
production of MMP-3 was further enhanced by attachment to LM-111 in presence of TGF-ß 
(23.19-fold ± 1.96 induction, p<0.004, mean 492±173 ng/mL, Fig. 1B). This LM-111 plus 
TGF-ß induced release of MMP-3 was significantly higher when compared to the stimulation 
of SF by LM-111 only (19-fold, p≤0.004) or TGF-ß only (3.3-fold, p≤0.009). 
 
Laminin-facilitated expression of MMP-3 is mediated by ß1-integrins 
 
Among the different integrins, 61 integrin represents a major receptor for LM-111 binding 
on fibroblasts. The expression of 61 integrin was verified on SF in vitro by 
immunocytochemistry (Fig. 2A, 2B). Pre-incubation of SF with anti-ß1 integrin mAb prior to 
seeding the cell into LM-111 coated flaskes reduced the number of cells attached in 
comparison to mock-treated controls (Fig. 2C, 2D). This confirmed that the mAB 4B4 
interfered with the laminin – integrin binding on the cell surface. In SF co-activated with 
TGF-ß and LM-111 the elevated MMP-3 mRNA expression was reduced significantly 
(p<0.05) by pre-incubation of SF with anti-ß1 integrin mAb (Fig. 3). The data confirm the 
expression of 1 integrin on SF in vitro and suggest a functional role of this integrin chain in 
the regulation of MMP-3 expression. 
 
 
 
 
Activation of ERK phosphorylation by LM-111 attachment and TGF-ß 
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Signal transduction pathways contributing to the TGF- and LM-111 induced MMP-3 
expression were investigated by immunoblot analysis. A weak phospho-ERK signal was seen 
in control cells prior to activation (Fig. 4A). Addition of 10 ng/mL TGF-ß to SF induced a 
transient phosphorylation of ERK at 10 to 30 min after induction (Fig. 4A, top). In contrast, 
phosphorylation of SMAD2 was not observed in control cells, but upon addition of TGF-ß 
(Fig. 4A, middle). The p38MAPK was detected in all samples (not shown), but phospho-
p38MAPK signals remained below detection levels (Fig. 4A, bottom). 
 
Co-activation of SF by TGF-ß in the presence of LM-111 induced an enhanced and extended 
phosphorylation of ERK at 10 to 60 min after induction (Fig. 4B, top). Again, phospho-
SMAD2 was not detected prior to stimulation but a long lasting phosphorylation of SMAD2 
was noted (Fig. 4B, middle). Moreover, phospho-p38MAPK signals were noted at 30 min 
(Fig. 4B, bottom) and phosphorylation of SAPK/JNK-1 was induced weakly as well (see Fig. 
S2, complementary files). 
 
Modulation of signal transduction contributing to elevated expression of MMP-3 
We further investigated, if the elevated expression of MMP-3 could be blocked by addition of 
SB203580, a p38MAPK blocker, or by PD98059, a MEK / ERK blocker, or by A-83-01, 
interfering with the SMAD2 signaling pathway [26]. Attachment of the cells to LM-111 
significantly enhanced the TGF-ß induced MMP-3 mRNA (3.1-fold, p<0.003; Fig. 5). 
Addition SB203580, PD98059 or A-83-01 prior to stimulation of the SF reduced the elevated 
expression of MMP-3 significantly (p≤0.005), confirming the importance of these pathways 
in TGF-ß and LM-111 dependent induction of MMP-3  (Fig. 5). 
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DISCUSSION 
 
Attachment of SF to LM-111 in the presence of TGF-ß induced a significant expression of 
MMP-3, a matrix protease that has been known for its involvement in tissue destruction in RA 
for a long time [30, 31]. MMP-3 has a rather broad substrate specificity and it degrades a 
variety of extracellular matrix proteins, including proteoglycans, collagens, fibronectin and 
laminins [32]. Therefore MMP-3 plays an important role for the pathomechanisms in RA. The 
induction of MMP-3 is associated with inflammatory cytokines, especially IL-1ß or TNF-.  
 
The additive effects of attachment of SF to laminins together with TGF-ß have not been 
investigated in detail so far, but some hints may have been derived from studies using 
Matrigel for investigation of invasive properties of SF [33]. In the present study, we show that 
attachment of SF to LM-111 sensitizes these cells to TGF- mediated signaling and 
significantly increases the expression of MMP-3, a relevant protease in RA. 
 
In recent studies, RA-SF showed a higher invasive score on Matrigel when compared to 
control cells and this correlated significantly with a higher expression of MMP-1, MMP-3 and 
MMP-10 [33]. Matrigel contains LM-111 as a major component. It therefore may activate SF 
in a way comparable to our experiments. Using a ribozyme approach to limit the expression 
of MMP-1 in RA-SF confirmed that this increased invasiveness of SF on Matrigel was 
associated with the expression of MMP-1 [34]. Our data, presented here, provide a molecular 
explanation for these findings as we see an increased expression of MMP-1 in SF upon 
attachment to LM-111. Addition of anti-TGF-ß antibodies to SF attached to LM-111 did not 
change the laminin-induced effects in our experiments (data not shown). This finding 
confirms that our LM-111 preparations used did not contain TGF-ß. However, for elevated 
production of MMP-1, co-signaling of LM-111 and TGF-ß is not sufficient, but LM-111 
together with TGF-ß significantly elevated both, the expression of MMP-3 mRNA and 
protein. 
 
As shown recently, most extracellular proteins derived from articular cartilage or connective 
tissue enhanced the attachment of SF mediated by integrins on the SF [8]. Stronger adherence 
of RA-SF to cartilage oligomeric protein (COMP) was associated with their expression of 
v1-integrin [35]. In other studies, elevated expression of 6- and 1-integrins on RA-SF 
correlated with their enhanced attachment to matrix proteins [9]. In mice lacking ß1-integrin 
expression in chondrocytes, cell motility and proliferation were impaired [36] and the 
expression of MMP-3, MMP-9 and MMP-13 was significantly reduced in these cells1. We 
corroborated these results as treatment of SF with mAb 4B4 blocked the attachment of SF to 
LM-111 and significantly reduced the induction of MMP-3. Further, the induction of MMP-3 
described here was induced by TGF- and LM-111 without addition of IL-1ß or TNF- to 
the cells. 
 
Transforming growth factor-ß is a multifunctional factor regulating cell division and 
differentiation. Depending on the individual experimental context, TGF-ß may activate or 
reduce proliferation and expression of target genes in a dose and time dependent manner [37]. 
This factor has also been shown to influence the homeostasis of the extracellular matrix [38]. 
TGF-ß may repress the PMA-induced expression of MMP-1 by SMAD signaling [39]. 
Without pre-stimulation by PMA, TGF-ß activates the expression of MMPs including MMP-3 
using a p38MAPK signaling pathway [40]. In our experiments, addition of TGF-ß activated 
the ERK and SMAD2 but not the p38MAPK pathways. The importance of SMAD2 for 
                                                
4
 A. Aszodi, poster # 90 at the Ann. Meeting German Connective Tissue Soc., Cologne (2005). 
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regulation of MMPs is supported by the fact that SMAD2 transgenic mice show elevated 
expression of MMP-1 and MMP–2 [41]. 
 
Activation of ERK1/2 by expression of a recombinant constitutively active MEK1 was 
sufficient to induce MMP-1 and MMP-3, but strong expression of MMP-1 and MMP-3 was 
observed when ERK1/2 were activated in combination with either SAPK/JNK or p38MAP 
kinases. Further, ERK was associated with the induction of transcription factors c-jun, junB 
and c-fos whereas p38 regulated MMP mRNA stability [24]. In our experiments, SF from 
one patient failed to induce the expression of MMP-3 when attached to LM-111 in presence 
of TGF-ß. Investigation of these cells revealed that phosphorylation of ERK had not occurred 
(data not shown). However, attachment to LM-111 seems to address the ERK-pathway in 
different mesenchymal cells [42].  
 
In our experiments phosphorylation of p38MAPK was not observed by TGF-ß alone but upon 
co-activation by LM-111 plus TGF-ß. We also quantified less MMP-3 mRNA after blocking 
p38MAPK activity in activated SF by the kinase blocker SB203580, corroborating that 
p38MAPK is involved in LM-111 plus TGF-ß induced expression of MMP-3 expression. A 
very weak signal of phospho-SAPK/JNK was noted in LM-111 plus TGF-ß activated SF but 
not in SF activated by TGF-ß alone (see Fig. S2, complementary materials), indicating that 
additional MAP kinases are addressed by these stimuli [43]. However, a detailed investigation 
of the contribution of other MAP kinases to the TGF-ß and LM-111 induced expression of 
MMPs in SF must await additional experiments [44].  
 
In summary, we show that attachment of RA-SF and OA-SF to LM-111 in the presence of 
TGF-ß is sufficient to yield a significant MMP-3 expression. Our data corroborate the 
importance of ERK, p38MAPK and SMAD2 signaling for efficient MMP-3 induction by 
TGF-ß and attachment to LM-111 in SF. Other cytokines such as IL-1ß or TNF- were not 
necessary for the expression of MMP-3 under these conditions. We conclude that pathologic 
expression of laminins in the synovium contributes to the elevated expression of MMP-3 in 
RA. This pathway may also explain in part the progression of cartilage destruction when RA 
patients are treated with anti-TNF (or anti-IL-1) therapies, as levels of TGF-ß did not change 
during etarnecept treatment of RA patients [45]. 
 
Acknowledgements: 
The authors thank Mrs. T. Abruzzese, A. Hack and M. Weis-Klemm for excellent 
experimental support, Dr. D. Alexander for technical advice and Prof. Klaus von der 
Mark (Univ. of Erlangen, FRG), for providing purified murine EHS LM-111 
 for coating of culture flasks. 
 
Authors Affiliations: 
 
Maik Hoberg, Maximilian Rudert: Dept. of Orthopedic Surgery, CRONA University 
Hospital, D-72076 Tübingen, Germany; 
 
Thomas Pap: Div. of Molecular Medicine of Musculoskeletal Tissue, Dept. of 
Orthopedics, Münster University Hospital, D-48149 Münster, Germany;  
 
Gerd Klein: Center for Medical Research (ZMF), Section for Transplantation 
Immunology, University of Tübingen, D-72072 Tübingen, Germany; 
 
 group.bmj.com on February 19, 2010 - Published by ard.bmj.comDownloaded from 
 11
Steffen Gay:  WHO Center for Exp. Rheumatol., University Hospital Zürich, & Zürich 
Center for Integrative Human Physiology (ZIHP); CH-8091 Zürich, Switzerland; 
 
Wilhelm K. Aicher: Center for Medical Research (ZMF), Dept. Orthop. Surg., 
Eberhard-Karls-University Medical School, D-72072 Tübingen, Germany. 
 
Grant support:  
The project was supported by DFG-grants Ai16/10-2 and Ai16/14-1 to WKA and in 
part by institutional funding. SG was supported by the European Community's FP6 
funding. This publication reflects only the author's views. The European Community is 
not liable for any use that may be made of the information herein. There are no 
disclosures for this study by any of the authors. 
 
Abbreviations: 
 
JNK jun-N kinase-1 (=SAPK) 
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MAP mitogen-activated protein 
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FIGURE LEGENDS 
 
Figure 1  
Activation of MMP-1 and MMP-3 expression in SF by LM-111 and TGF-ß  
(A) The SF (106 per flask) were incubated on LM-111-coated flasks (n = 14), in presence of 
10 ng/mL TGF- in normal tissue culture flasks (n = 10), or in LM-111 coated flasks in 
presence of 10 ng/mL TGF- for 24 hours (n = 13). Cells were harvested and mRNA 
expression patterns of MMP-1 (hatched bars) and MMP-3 (solid bars) were investigated by 
qRT-PCR in comparison to controls. Attachment of SF to LM-111 in presence of TGF-ß 
induces significant MMP-1 (2.73-fold, p<0.004) and MMP-3 (14.21-fold, p<0.004) mRNA 
responses. Induction of MMP-3 was significantly higher (bracket, p<0.018) when compared 
to MMP-1. Each data point represents the mean induction index ± standard deviation over not 
activated controls (=1).  
(B) Supernatants were harvested after 24 h of incubation of SF as described above and MMP-
1 (hatched bars) and MMP-3 (black bars) concentration were measured by ELISA. 
Attachment of SF to LM-111 in presence of TGF-ß induces a significant MMP-3 secretion 
(23.19-fold, p< 0.004). This co-activation by LM-111 in presence of TGF-ß was significantly 
higher when compared to MMP-3 induction by LM-111 or TGF-ß alone (brackets, p≤0.004, 
and p≤0.009, respectively). Data show the mean MMP concentrations (pg/mL) ± standard 
deviations from quadruplicate experiments using supernatants of SF from 3 donors.  
 
Figure 2 
Detection of integrin expression and integrin-mediated attachment by synovial fibroblasts 
Expression of CD49f (integrin 6-chain) and CD29 (integrin 1-chain) on SF is shown by 
staining of the cells with mAB GoH3 (1:100) followed by Cy3-labelled anti-rat serum 
(1:1000, Fig. 2A) and with mAB 4B4 (1:100, Fig. 2B) followed by Cy2-labelled anti-mouse 
serum (mag. 20x, n=3). The SF attach to LM-111-coated surfaces within 60 to 90 min upon 
inoculation (Fig. 2C, mag. 4x). Pre-incubation of SF with 10 mg/mL mAB 4B4 prior to 
seeding reduces the number of cells attached to LM-111 (Fig. 2D, mag. 4x, n=2). 
 
 
Figure 3 
Modulation of MMP-3 expression by blocking ß1-integrin on synovial fibroblasts 
 
Synovial fibroblasts were harvested and 106 cells were inoculated on normal plates 
(=controls),on LM-111 coated plates in presence of TGF-ß without (ø) or after pre-incubation 
with anti-ß1 integrin mAB (= 4B4). Pretreatment with mAB 4B4 reduced MMP-3 mRNA 
induction significantly (bracket, p<0.05). Data show the mean values ± standard deviations of 
individual inductions using SF from 4 donors. 
 
Figure  4 
Signal transduction pathways activated by TFGand LM-111 plus TGF-ß  co-activation 
 
The RA-SF were incubated for different periods of time ranging from 10 min to 22 h with 10 
ng/mL rhTGF-ß1 (A) or by LM-111 plus TGF-ß co-activation (B). The phosphorylation of 
ERK1/2, SMAD2 and p38MAP kinases was investigated by immunoblot. A recombinant 
protein mix (ø) and cells w/o TGF-ß activation (0) served as negative controls (left) and a 
phosphorylated molecular size protein marker (M) was used to confirm the transfer of 
proteins (right). Addition of TGF-ß induced a transient phosphorylation of ERK (A, top) and 
SMAD2 (A, middle) but no p38MAPK signal (A, bottom). By co-activation using TGF-ß in 
presence of LM-111 an extended ERK-phosporylation (B, top), transient SMAD2 (B, middle) 
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and p38MAPK (B, bottom) signals (were seen). The molecular weight of proteins (MW) is 
shown in kDa. For detection of phosphorylated p38MAPK, extracts of UV-treated NIH/3T3 
cells were used as positive controls (P). 
 
Figure 5 
Modulation of MMP-3 activation by blocking the signal transduction pathway 
 
The RA-SF were activated by incubation on LM-111 coated flasks by addition of TGF-ß or 
upon co-activation in presence of SB203580, PD98059 or A-83-01. The MMP-3 encoding 
mRNA amounts were enumerated by qRT-PCR in activated cells in comparison to untreated 
controls (n=8, left). Co-activation induced MMP-3 transcripts significantly (3.1 ± 1.5-fold, 
p<0.005, n=8). Transcript amounts encoding MMP-3 were reduced significantly by addition 
of SB203580 (4.2-fold, p≤0.005, n=5), PD98059 (3.9-fold, p≤0.001, n=8), or A-83-01 (2.3-
fold, p< 0.004, n=7). 
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Complementary Materials 
 
MATERIALS AND METHODS 
 
Cell culture 
Synovial fibroblasts were isolated from surgical samples of sixteen RA patients diagnosed 
according to the revised American College of Rheumatology (ACR) criteria for RA and 
twelve OA patients after written consent [22] (Table 1). The SF were expanded in vitro as 
described [23]. In brief, tissues were minced with scissors and scalpel, incubated in 
collagenase / dispase / PBS to degrade the extracellular matrix. Fibroblasts were expanded in 
DMEM medium enriched with antibiotics (Sigma-Aldrich, St. Louis, MO), insulin, 
transferrin, selenous acid (ITS, Collaborative Res., Lexington, MA) and 10% FCS 
(Biochrome, Berlin, FRG), called complete medium. All studies were approved by the local 
ethics committee.  
 
For induction experiments, cells in passages 3 or 4 were stimulated for 24 h in complete 
medium in presence of 0.1 to 10 ng/mL rhTGF-1 (Roche, Mannheim, FRG) [46]. Cells in 
complete medium w/o TGF-ß served as controls. Furthermore, cells were incubated for 24 h 
in LM-111 coated flasks (murine EHS-laminin, BD Biosciences, Bedford, MA) and 
differences of gene expression were investigated in comparison to cells grown at the same 
densities in uncoated polystyrol cell culture flasks (BD Biosciences). To confirm the data, 
flasks were also coated overnight at 4°C with 10 g/mL of different batches of LM-111: 
affinity chromatography purified murine EHS-laminin (a generous gift of K. von der Mark, 
Univ. of Erlangen, FRG) or commercially available murine LM-111 laminin (BD 
Biosciences). For controls, plates were coated with LM-511/521 (human placenta laminin, 
affinity chromatography purified, 10 g/mL, Chemicon, Temecula, CA). Coated flasks were 
rinsed twice with PBS and SF attachment and gene induction were investigated.  
 
To modulate the effects of laminin, 106 SF were incubated in 10% FCS/DMEM complete 
medium in presence of anti-CD29 monoclonal antibodies (anti-1 integrin, clone 4B4, 
Beckman-Coulter, Krefeld, FRG, 10 g/mL) for 60 min on ice to block integrin receptors. 
Then the cells were incubated in normal cell culture flasks or in LM-111 coated flasks (24 h, 
37°C) in the presence or absence of TGF-ß to investigate the gene expression patterns in 
comparison to mock-treated controls. The viability of the fibroblasts upon treatment was 
enumerated by trypan-blue dye exclusion. It was greater than 90% in all experiments of this 
study. 
 
Transcript Analysis 
The RNA was extracted from 106 cells in passage 3 or 4 using a spin column technique and 
contaminating DNA was removed by a DNase degradation step (RNeasy, Qiagen, Hilden, 
FRG). To generate cDNA, 1 g of total RNA was reverse transcribed using oligo-(dT) 
primers and AMV-reverse transcriptase (Promega, Madison, WI). To measure steady state 
mRNA levels of transcripts encoding matrix proteases, a quantitative RT-PCR system 
(LightCycler®, Roche) and commercially available primer pairs (SearchLC, Heidelberg, 
FRG) were used. Amplification of target DNA was performed in 35 PCR cycles. Following 5 
initial cycles (95°C 10 s, 68°C 10 s, 72°C 16 s, temperature transition rate 20°C s-1) the 
annealing temperature was dropped to 58°C with a step size of 0.5°C per cycle. Quantification 
of GAPDH mRNA in each individual sample and a recombinant standard DNA (Roche) 
served as controls in each PCR. The quality of amplification was investigated by melting 
point analysis of each individual run (95°C, 58°C 10 s, 95°C). The PCR products were then 
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separated by electrophoresis in 1.5% agarose gels and visualized by UV-activated ethidium-
bromide fluorescence to confirm the expected size. 
 
For end-point amplification of cDNA, the PCR device (Biometra, Göttingen, FRG) was 
programmed for 30 PCR cycles (60 sec. 94oC, 60 sec. 56oC and 120 sec. 72oC, respectively) 
followed by 5 min. at 72°C for primer extension. To detect mRNAs encoding LM chains the 
following primer pairs were used (all 5’-3’): LM1: for TGCAGAGCCGTTTTACTGG, rev 
TGCTGTAATCCTTGACCATACG (357 bp, Genbank # NM_005559.2, starting at pos 
3733). LM5: for GACAGTGCCCTGCTCTACTACC, rev 
CCCCAAACTGGTAAGGAGTCTC (562 bp, Genbank # NM_005560.3, starting at pos 
9539), LM1: for TGCTTCTGCTATGGTCATGC, rev CCGTGGCCAGGTAAACAG (337 
bp, Genbank # NM_002291.1, starting at pos 1146). LM1: for 
CATCTCTCGAGTGGTCCTCTG, rev GCTTCATGGAGCCTGAAGAC (283 bp, Genbank 
# NM_002293.2, starting at pos 1906). The GAPDH PCR served as external control of each 
cDNA batch: for TGAAGGTCGGAGTCAACGGATTTGGT, rev 
CATGTGGGCCATGAGGTCCACCAC, 983 bp, Genbank # NM_002046.2 starting at pos. 
86). The PCR products were visualized after electrophoresis as described above. 
 
To investigate signal transduction pathways, cells were incubated in normal culture flask or 
on LM-111 coated flasks overnight. To block the p38 MAPK pathway, 20 M SB203580 
[24] and to block the MEK-ERK pathway, 20 M PD98059, were utilized [25], to block 
TGF-ß dependent SMAD2 signaling, a novel ALK-5 blocker was used (100 nM A-83-01, 
TGF-ßR-I serin/threonine kinase blocker, [26], all from Cabiochem, Schwalbach, FRG). 
These compounds were added to the SF 10 min prior to stimulation by TGF-ß. For 
stimulation, 10 ng/mL of rhTGF-ß1 were added to the cells. Untreated cells served as 
controls. After overnight incubation cells were harvested to measure changes in the 
expression of MMP-3 mRNA by quantitative RT-PCR. 
 
Immunocytochemistry 
The expression of laminin and integrin was detected by immunocytochemistry. In brief, SF 
were inoculated on chamber slides. Medium was removed, cells were washed twice with PBS, 
fixed in cold methanol and samples were blocked with 0.1% BSA in PBS. For detection of 
LM-111, slides were incubated with purified rabbit anti-LM-111 antiserum (1:100, [47]) in 
BSA/PBS in wet chambers for 2 h at 20oC. Slides were washed and incubated for 90 min at 
20oC with Cy3-labelled goat anti-rabbit Ig (1:1000, Dianova, Hamburg, FRG). Binding of 
secondary antibodies in absence of primary reagent served as negative control. Nuclei were 
counterstained using 4’,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich). For detection of 
61 integrin, slides were incubated with affinity purified anti-CD49f mAb (GoH3, anti-
integrin 6-chain, 1:100, BD-Pharmingen, San Diego, CA) or anti-CD29 mAb (4B4, anti-
integrin 1-chain, 1:100, Beckman-Coulter) followed by affinity purified Cy3-labelled anti 
rat-IgG (1:1000, Dianova, Hamburg, FRG) or Cy2-labelled anti-mouse IgG (1:1000, 
Biotrend, Cologne, FRG), respectively. Slides were embedded, covered and micrographs were 
taken using a microscope (Axiophot, Zeiss, Oberkochen, FRG) at 20x objective 
magnification.  
 
 
 
ELISA 
The secretion of MMPs was measured in SF supernatants by enzyme-linked immuno-sorbent 
assay (ELISA). The cells were seeded in flasks in complete medium at starting density of 
1.3x105cm-1 and activated for 24 h by addition of 10 ng/mL rhTGF-, by attachment to LM-
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111 or by attachment to LM-111 in the presence of 10 ng/mL TGF-. Controls were 
incubated in normal tissue culture flasks w/o TGF-or LM-111. Supernatants were harvested 
after 24 h of incubation, pre-cleared by centrifugation (20000xg, 4°C, 5 min) and 100 l 
aliquots were subjected to ELISA as described by the supplier (R&D Systems, Minneapolis, 
MN) using a microplate scanning spectrophotometer (scan, Bio-Tek Instruments, Winooski, 
VM).  
 
Immunoblot Analysis 
To investigate cytoplasmic pathways involved in TGF-ß or LM-111 mediated signal 
transduction, phosphorylation of signaling proteins was investigated in induction kinetic 
experiments (10 min to 22 h). After activation, 2x106 cells were harvested, lysed and 
subjected to SDS-PAGE and immunoblot analysis as described [28]. In brief, cells were 
washed with cold PBS, harvested by mechanical detachment, collected by centrifugation and 
lysed in 100 L buffer containing 150 mM NaCl, 50 mM Tris/HCl pH 8, 1% NP-40 and a 
cocktail of proteinase inhibitors (Roche). The extracts were mixed and stored overnight at –
70°C. After thawing the samples, unsoluble debris was removed from the extracts by 
centrifugation (20000xg, 4°C, 30 min). The concentration of proteins in the extracts was 
measured by a colorimetric assay according to the instructions of the manufacturer (Bio-Rad, 
Hercules, CA). An aliquot of 100 g total cellular protein was mixed with Laemmli sample 
buffer, denatured at 95°C and then separated by electrophoresis in a 10% SDS-PAGE. 
Proteins were transferred onto Nylon membranes, blocked and probed overnight at 4°C with 
anti-phospho-ERK1/2 (Thr202/Tyr204), anti-phospho-JNK/SAPK (Thr183/Thr185), anti-
total p38MAPK, anti-phospho-p38MAKP (Thr180/Tyr182), anti-phospho-SMAD2 
(Ser465/467) antibodies (all from Cell Signaling Technology, Beverly, MA). After intensive 
rinsing of the membrane, binding of the primary antibodies was detected using peroxidase-
labelled goat anti-rabbit-IgG antiserum (Dianova). The binding of antisera was visualized by 
enhanced chemoluminescence (ECL, Amersham Biosciences, Freiburg, FRG) and recorded 
by a luminescence-sensitive CCD camera system (Diana, Raytest Inc. Straubenhardt, FRG).  
 
Statistics 
For statistical analysis of experimental data, a two-sided modified Student’s t-test was 
performed and p-values of data sets equal of lower than 0.05, 0.01 or 0.001 were considered 
to be statistically significant and marked (*, **, ***) in the artwork accordingly. Each data point 
shown represents the mean value ± standard deviation from individual experiments using SF 
from n different patients (4 ≤ n ≤ 14). In the figures, statistically significant differences in 
activated cells in comparison to not or mock-treated controls are marked by asterisks. 
Statistically significant differences among induced samples are marked by bars. 
 
Legends to Fig. S1 / S2 in the supplement: 
 
Figure S1: 
Detection of LM-111 expression by immunocytochemistry and RT-PCR 
The RA-SF were grown on chamber slides and labelled with rabbit anti-EHS-laminin 
antiserum (1:100, = LM-111), washed and counterstained with Cy3-conjugated goat anti-
rabbit serum (1:1000). Nuclei were visualized by DAPI (upper panel, left). Cells reacted with 
detection serum only followed by DAPI stain served as negative controls (upper panel, right, 
n=3). Laminin 1-, 1- and 1- chains encoding mRNAs were detected by RT-PCR in all 
SF (n = 6, lanes 1 – 6). The LM5 mRNA was not detected. GAPDH RT-PCR served as 
external control in each cDNA sample. The 100 bp DNA size marker in shown on the left of 
each gel (M, lower panels).  
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Figure S2: 
Phosphorylation of SAPK/JNK-1 by co-activation of SF with LM-111 and TGF-ß 
 
The RA-SF were incubated for different periods of time ranging from 10 min to 22 h with 10 
ng/mL rhTGF-ß1 or on LM-111 coated flasks in presence of 10 ng/mLTGF-ß as indicated. 
Cells were harvested and protein extracts were analysed by immunoblot. Cells without 
stimulation served as controls (0). Phospho-SAPK/JNK-1 signals were barely detectable in SF 
activated by TGF-ß alone (top). In contrast, in cells activated by LM-111 together with TGF-ß 
30 min after induction a phospho-SAPK/JNK-1 signal was noted and a weak phospho-
SAPK/JNK-1 signal was observed 60 min after stimulation. A phospo-protein molecular 
weight marker (M) was used to confirm transfer of proteins. The molecular mass of proteins 
is shown in kDa. 
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